protein(a) (Lp(a)) and apolipoprotein were measured by turbidimetric immunoassay (Lp(a), Cosmo Laboratory, Tokyo, Japan; apolipoprotein, Daiichi Pure Chemical Co, Ltd). Plasma CRP was measured by the Latex aggultination method (Dade Behring, Tokyo, Japan).
Patients were followed for a mean of 50±4 months after the determination of various factors, and information on cardiac events was obtained. Cardiac events were defined as follows: (i) sudden death due to cardiac causes (ie, death within 1 h of the onset of cardiac symptoms); (ii) fatal or nonfatal myocardial infarction (according to standard diagnostic criteria), and (iii) the development of unstable angina pectoris (worsening of angina within the previous 4 weeks or angina at rest). Not considered as a cardiac event was restenosis after percutaneous transluminal coronary angioplasty (PTCA).
Statistical Analysis
Results are expressed as mean ± SD. Means or proportions for clinical characteristics and measured risk factors were compared between the cardiac events group and the no cardiac events group by means of Student's t test or the chi-squared statistic. The Cox proportional hazards model was used to estimate the contribution of various risk factors to the prediction of cardiac events during the follow-up period. Kaplan-Meier curves for the freedom from cardiac events were calculated to describe the occurrence of such events by high plasma concentrations of t-PA or CRP. Differences between the high and low plasma concentrations of these factors were tested by the log-rank test. A level of p<0.05 was accepted as statistically significant.
Results
Baseline clinical characteristics of the subjects evaluated are shown in Table 1 . The 106 patients who could be followed up exhibited 11 cardiac events, which included 7 patients with unstable angina and 4 patients with acute myocardial infarction, but no cases of cardiac death. Baseline characteristics, therapy during the follow-up period, and levels of risk factors according to cardiac events are shown in Table 2 . There were no differences between the groups with/without cardiac events with respect to sex, age, incidence of smoking, hypertension, diabetes mellitus, or therapy with PTCA or medication. Of the factors evaluated, levels of t-PA, apolipoprotein CII, and CRP in the group with cardiac events were higher than those in no cardiac event group. The level of HDL-C in the cardiac event group was below that in the no cardiac event group, but there were no differences between the 2 groups with respect to other factors.
The results of analyses of the predictors of the risk of cardiac events during follow-up using the univariate Cox model are shown in Table 3 . To compare the predictive power of each, hazard ratios were calculated for 1-SD differences in each variable. Of the various factors, only t-PA, HDL-C, apolipoprotein CII and CRP were found to be significant predictors of cardiac events.
The stepwise variable choice model of Cox proportional hazards analysis using all the variables measured at entry selected only t-PA and CRP as significant predictors of cardiac events (t-PA: relative risk per SD 1.60, p=0.0007; CRP: relative risk per SD 1.55, p=0.0230). We further investigated whether the relationships between t-PA or CRP and cardiac events might be affected by other risk factors or choice of therapy during the follow-up period (Table 4) . Controlling for other risk factors or therapy with PTCA or use of drugs did not reduce the relation between an elevated t-PA level and the cardiac event. The relative risk of cardiac events for 1 SD of CRP concentration was not affected when controlled for smoking, hypertension, diabetes mellitus, therapy with PTCA or use of drugs, TG, TC, and fibrinolytic factors, but was not statistically significant when controlled for HDL-C.
Kaplan-Meier curves for freedom from cardiac events by t-PA and CRP levels are shown in Fig 1. The risk of having a cardiac event was higher in patients with a high concentration of t-PA (≥10 ng/ml) and CRP (≥0.5 mg/dl) than in patients with low concentrations of those factors.
Discussion
The present study showed that in Japanese patients with coronary atherosclerotic lesions, the presence of high plasma levels of t-PA and CRP was most associated with an increased risk of cardiac events.
This finding agrees with the results of recent prospective studies in patients with angina pectoris or myocardial infarction, as well as in healthy men. [26] [27] [28] [29] [30] In the ECAT Kaplan-Meier curves for freedom from cardiac events according to tissue-plasminogen activator (t-PA) and C-reactive protein (CRP) levels. The risk of having a cardiac event was significantly higher in patients with a high concentration of t-PA (≥10 ng/ml) and CRP (≥0.5 mg/dl) than in patients with a low concentration of either.
multicenter study of 3,043 patients with angina pectoris, 29 t-PA antigen was the strongest predictor of a subsequent coronary event followed by PAI-1 antigen among the 10 fibrinolytic variables, following adjustment for center, age and sex. Furthermore, the relative risk per SD of t-PA antigen was 1.50 in the ECAT study, which is comparable to that in our study (ie, 1.63). However, the plasma level of PAI-1, which is considered to be a dominant factor in the balance of fibrinolytic activity, 31, 32 did not predict cardiac events in our present study. This discrepancy may be due to the fact that assays for t-PA antigen detect mainly inactive t-PA/PAI-1 complexes 33, 34 and that PAI-1 antigen assays detect free active PAI-1, as well as complexes of t-PA/PAI-1 35 and the latent PAI-1 that may be secreted by platelets. 36 A smaller intra-individual variability for t-PA antigen compared with PAI-1 antigen could explain the disparity between our results and those reported previously. 26, 37 An increase in the synthesis of t-PA antigen may be induced by a dysfunction of the endothelial cells in patients with coronary atherosclerotic lesions. This hypothesis is consistent with the concept that progressive atherosclerosis triggers such reactive mechanisms as the activation of the endogenous fibrinolytic system. 38 We also found that a slight increase in CRP is significantly associated with an increased risk of cardiac events. This result is compatible with previous studies demonstrating the ability of CRP to predict future events during several years of follow-up in patients with angina pectoris as well as in apparently healthy men. [18] [19] [20] [21] The relative risk per SD of CRP was 1.49 in the present study, which is almost comparable to that in the previous studies (ie, 1.24 18 and 1.45 19 ). However, the prognostic value of CRP in the acute phase of unstable angina pectoris is controversial. Liuzzo et al showed that elevated CRP in patients with unstable angina predicted a poor outcome during hospitalization, 17 whereas Oltrona et al have recently reported that, in a large population with unstable angina, elevation of CRP did not predict an adverse outcome in the early phase after an acute episode. 39 These observations suggest that the main cause for CRP elevation is different between the chronic and acute states of inflammation.
Furthermore, in the present study the risk of cardiac events associated with the level of CRP was modified by HDL-C only, which suggests that the inflammatory response, as shown by a high level of plasma CRP, observed in patients with cardiac events may reflect inflammation within the atherosclerotic lesions, because a low level of serum HDL-C is a known risk factor for atherosclerosis. However, Ridker et al recently reported that the baseline CRP level, with low as well as high levels of TC and the TC:HDL-C ratio, was predictive of risk for future myocardial infarction. 21 This discrepancy may be due to differences in the study subjects because their data were from apparently healthy men who probably had less atherosclerotic lesions than the present study's subjects. In other words, the main cause of the elevation of CRP may differ between study subjects.
It has also been hypothesized that the bronchial inflammation caused by smoking is responsible for the observed association between CRP level and vascular risk. 40 Howard et al recently showed an association between carotid wall thickness and life-long exposure to cigarette smoke. 41 However, in the present study, CRP was a significant predictor of cardiac events even after adjustment for the smoking history. Other reports have shown that infections with Helicobacter pylori and Chlamydia pneumoniae were associated with coronary heart disease, various cardiovascular risk factors, and the increased production of CRP. [42] [43] [44] [45] On the other hand, Anderson et al have recently reported that infectious serology might be less predictive than previously suggested. 46 However, we did not evaluate these factors.
Concerning the lipid profile, we found that HDL-C and apolipoprotein CII were significant predictors of cardiac events, whereas TC, TG, and other apolipoproteins were not significant predictors, when using univariate Cox model analyses. These results are consistent with those of previous studies in which HDL-C was a better discriminator of the risk of myocardial infarction than was apolipoprotein AI. 47, 48 However, neither HDL-C nor apolipoprotein CII was chosen as a significant predictor by the stepwise variable choice model of Cox proportional hazards analysis using all of the variables measured at study entry. These findings indicate that such lipid factors are secondary to t-PA or CRP in predicting the occurrence of cardiac events.
With regard to the choice of therapy, there were no differences between the groups with/without cardiac events with respect to therapy by PTCA or medication, which indicated that neither PTCA nor drugs had a favorable effect on the prognosis of patients with coronary atherosclerotic lesions. This result may be due to the fact that patients who had more extensive coronary artery disease had been treated with more positive therapy (PTCA) or more drugs.
Study Limitations
This study has several limitations. First, we evaluated 106 patients, a smaller number than evaluated in other prospective studies on the predictive value of risk factors. Second, our analyses are based on a single base-line determination that may not reflect the patient's status over long periods. Furthermore, this study included only patients with coronary atherosclerosis without controls, so that the ability to generalize these findings is limited.
